Capacity strengthening

EVI promotes capacity strengthening in various aspects of vaccine evaluation and manufacture, often in parallel with funding of the development of specific candidate products and harmonisation efforts.

EVI seeks to address the relative weakness of infrastructure in Developing Countries for vaccine development, whether in production to Good Manufacturing Practice standards or the conduct of clinical trials.

The UCAD team in the brand new investigational site in Keur Soce, Senegal January 2011
The UCAD team in the brand new investigational site in Keur Soce, Senegal January 2011